People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osprey Pharmaceuticals Usa Inc | — | Pharmaceuticals | Series A | $5.9M | $182.5M | 2009 |
| Profound Medical Corp. | — | Biotechnology | Series A | $877K | $31.7M | 2017 |
Jean-Francois Pariseau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jean-Francois Pariseau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Hamer | 1 | 7 |
| Kenneth Galbraith | 1 | 6 |
| Nassim Usman | 1 | 4 |
| Arun Menawat | 1 | 3 |
| Rashed Dewan | 1 | 1 |
| Martial LaCroix | 1 | 1 |
| Jack Anthony | 1 | 1 |
| Barbara Finck | 1 | 1 |
| Damian Lamb | 1 | 1 |
| William Curran | 1 | 1 |
| Samira Sakhia | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.